POU2F3
POU domain, class 2, transcription factor 3
Also known as: Epoc-1, OCT11, PLA-1, PO2F3_HUMAN, Skn-1a
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UKI9
- Gene
- POU2F3
- Ensembl
- ENSG00000137709
- Chromosome
- 11
- Canonical length
- 436 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
OverviewNCBI Gene
This gene encodes a member of the POU domain family of transcription factors. POU domain transcription factors bind to a specific octamer DNA motif and regulate cell type-specific differentiation pathways. The encoded protein is primarily expressed in the epidermis, and plays a critical role in keratinocyte proliferation and differentiation. The encoded protein is also a candidate tumor suppressor protein, and aberrant promoter methylation of this gene may play a role in cervical cancer. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Sep 2011]
Canonical amino-acid sequenceUniProt
436 residues, UniProt reviewed canonical sequence.
>Q9UKI9|POU2F3
1 MVNLESMHTD IKMSGDVADS TDARSTLSQV EPGNDRNGLD FNRQIKTEDL SDSLQQTLSH
61 RPCHLSQGPA MMSGNQMSGL NASPCQDMAS LHPLQQLVLV PGHLQSVSQF LLSQTQPGQQ
121 GLQPNLLPFP QQQSGLLLPQ TGPGLASQAF GHPGLPGSSL EPHLEASQHL PVPKHLPSSG
181 GADEPSDLEE LEKFAKTFKQ RRIKLGFTQG DVGLAMGKLY GNDFSQTTIS RFEALNLSFK
241 NMCKLKPLLE KWLNDAESSP SDPSVSTPSS YPSLSEVFGR KRKKRTSIET NIRLTLEKRF
301 QDNPKPSSEE ISMIAEQLSM EKEVVRVWFC NRRQKEKRIN CPVATPIKPP VYNSRLVSPS
361 GSLGPLSVPP VHSTMPGTVT SSCSPGNNSR PSSPGSGLHA SSPTASQNNS KAAVNSASSF
421 NSSGSWYRWN HSTYLHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against POU2F3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 45 nTPM
Expression across tissuesHPA
Tissue
- skin: 45 nTPM
- parathyroid gland: 5.8 nTPM
- breast: 1.9 nTPM
- seminal vesicle: 1.9 nTPM
- vagina: 1.8 nTPM
- epididymis: 1.6 nTPM
Single-cell type
- tuft cells: 738 nCPM
- epididymal basal cells: 66 nCPM
- suprabasal keratinocytes: 57 nCPM
- respiratory ionocytes: 43 nCPM
- alveolar cells type 2: 34 nCPM
- basal keratinocytes: 31 nCPM
Immune cell
- basophil: 0.2 nTPM
- neutrophil: 0.2 nTPM
- naive B-cell: 0.1 nTPM
- NK-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- cerebellum: 1.4 nTPM
- cerebral cortex: 1.4 nTPM
- basal ganglia: 1.3 nTPM
- white matter: 1.3 nTPM
- hippocampal formation: 1.2 nTPM
- pons: 1.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about POU2F3.
Disease | AutoantibodyPubMed
Conditions in which antibodies against POU2F3 are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for POU2F3 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
7 publications
- Platelet membrane glycoprotein IIIa contains target antigens that bind anti-platelet antibodies in immune thrombocytopenias.
1984 · J Clin Invest · RCR 6.1 · 178 citations - Cumulative experience with a simplified solid-phase radioimmunoassay for the detection of bound antiplatelet IgG, serum auto-, allo-, and drug-dependent antibodies.
1982 · Blood · RCR 1.6 · 32 citations - Post-transfusion purpura: response to steroids and association with red blood cell and lymphocytotoxic antibodies.
1982 · Br J Haematol · RCR 1.6 · 32 citations - Posttransfusion purpura associated with an autoantibody directed against a previously undefined platelet antigen.
1987 · Blood · RCR 1.3 · 30 citations - [Inhibition of platelet migration. A simple technic for typing of PLA1 and the detection of platelet allo- and autoantibodies].
1978 · Rev Fr Transfus Immunohematol · RCR 0.5 · 8 citations
Show 2 more
- Refractory thrombocytopenia due to anti-PLA1 antibodies following autologous peripheral blood stem cell transplantation: case report and review of literature.
1996 · Bone Marrow Transplant · RCR 0.2 · 6 citations - Fab-mediated binding of glycoprotein Ib/IX and IIb/IIIa specific antibodies in chronic idiopathic thrombocytopenic purpura.
1995 · Br J Haematol · RCR 0.1 · 3 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.32
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- epidermis development
- host-mediated suppression of viral transcription
- keratinocyte differentiation
- positive regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
- wound healing
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- identical protein binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of POU2F3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads POU2F3 as an antibody target. Whether an autoantibody or antibody against POU2F3 could matter depends on whether native POU2F3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
POU2F3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label POU2F3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...